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Biomineral coatings have been extensively used to enhance the osteoconductivity of polymeric scaffolds. Nu-
merous porous scaffolds have previously been coated with a bone-like apatite mineral through incubation in
simulated body fluid (SBF). However, characterization of the mineral layer formed on scaffolds, including the
amount of mineral within the scaffolds, often requires destructive methods. We have developed a method using
micro-computed tomography (m-CT) scanning to nondestructively quantify the amount of mineral in vitro and
in vivo on biodegradable scaffolds made of poly (L-lactic acid) (PLLA) and poly (e-caprolactone) (PCL). PLLA
and PCL scaffolds were fabricated using an indirect solid freeform fabrication (SFF) technique to achieve or-
thogonally interconnected pore architectures. Biomineral coatings were formed on the fabricated PLLA and PCL
scaffolds after incubation in modified SBF (mSBF). Scanning electron microscopy and X-ray diffraction con-
firmed the formation of an apatite-like mineral. The scaffolds were implanted into mouse ectopic sites for 3 and
10 weeks. The presence of a biomineral coating within the porous scaffolds was confirmed through plastic
embedding and m-CT techniques. Tissue mineral content (TMC) and volume of mineral on the scaffold surfaces
detected by m-CT had a strong correlation with the amount of calcium measured by the orthocresolphthalein
complex-one (OCPC) method before and after implantation. There was a strong correlation between OCPC pre-
and postimplantation and m-CT measured TMC (R2 = 0.96 preimplant; R2 = 0.90 postimplant) and mineral vol-
ume (R2 = 0.96 preimplant; R2 = 0.89 postimplant). The m-CT technique showed increases in mineral following
implantation, suggesting that m-CT can be used to nondestructively determine the amount of calcium on coated
scaffolds.
Introduction
Porous scaffolds have been engineered using a varietyof biodegradable materials, including poly (L-lactic acid)
(PLLA), poly (lactide-co-glycolide acid) (PLGA), and poly (e-
caprolactone) (PCL) to repair bone defects. These materials
are readily formed into three-dimensional (3D) architectures,
degrade in desirable periods relative to bone formation, and
are relatively radio transparent, which allows bone healing
to be readily tracked by X-ray or computed tomography
(CT). However, a significant disadvantage is their poor
osteoconductivity compared to hydroxyapatite (HAP) and
tricalcium phosphate scaffolds. Polymer scaffold osteo-
conductivity can be improved by deposition of a surface
biomineral coating using a simulated body fluid (SBF) con-
taining similar ion components to human blood plasma.1–3
Biomineralization has been successfully applied to various
biomaterials, including polymers,4–9 and the composites of
polymers and HAP or other calcium phosphates.6,10,11 The
resulting coatings have been characterized in vitro using
destructive methods, such as electron microscopy. However,
the 3D distribution of mineral coatings within scaffold ar-
chitectures has not been well characterized due to limitations
in the destructive, inherently 2D techniques.
Micro-computed tomography (m-CT) has been widely
used to nondestructively assess fabricated architectures
of biodegradable polymer and calcium phosphate scaf-
folds.12–15 In this system, images are obtained by material
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attenuation of X-ray to evaluate scaffold geometry and
simulate mechanical behavior.13,14,16 The existence of bio-
mineral coatings on polymer scaffold surfaces also have been
examined using m-CT since polymer is almost radio trans-
parent compared to other radio-dense materials.17–19 How-
ever, the 3D volume and distribution of mineral coating
within porous scaffolds has not been precisely quantified
and verified versus destructive methods. Furthermore,
changes in mineral coating following implantation in vivo
have not been rigorously quantified in 3D. The ability to
rigorously quantify the volume and spatial distribution of
coatings within 3D architectures following SBF incubation
and track coating changes over time in vivo are unmet needs.
PLLA and PCL scaffolds have been fabricated with con-
trolled porous architectures using computer-aided design
and indirect solid freeform fabrication (SFF).20–22 The ad-
vantage of using controlled architectures as opposed to
conventional methods like particle leaching23–26 is that the
same architecture can be reproduced in different materials
(like PLLA and PCL), allowing a direct comparison of sub-
strate effects on mineral coating without different architec-
tures confounding the results. Furthermore, the fully
connected designed pore architectures enhance the ability to
coat the architectures using fluid-based methods like SBF
incubation.
We hypothesized that PLLA and PCL scaffolds with rig-
orously controlled pore architectures could be successfully
coated with biomineral layers and that the biomineral coat-
ings on the scaffolds could be nondestructively analyzed
using m-CT after in vitro and in vivo experiments. PLLA and
PCL scaffolds were fabricated using an indirect SFF tech-
nique and subsequently coated with biomineral layers
through incubation in a modified SBF (mSBF). The scaffolds
were subcutaneously implanted in back of mice for 3 and 10
weeks. The morphologies and cross sections of the mineral
coating were characterized using a scanning electron mi-
croscope (SEM), X-ray diffraction (XRD), and plastic em-
bedding techniques to qualify the mineral coatings. The
amount of mineral was quantified using a combination of m-
CT and calcium (Ca) measurements techniques before and
after implantation.
Methods
Porous scaffold design and fabrication
Cylindrical porous PLLA and PCL scaffolds 5mm diam-
eter and 3mm height were fabricated using an indirect SFF
(Fig. 1).21,27 Scaffolds were designed using image-based
technique, where a unit cell with orthogonally inter-
connected pore channels was designed and then repeated in
three dimensions to fill a desired scaffold outer dimension
(5 · 3mm).28 Resulting image representations were con-
verted to stereolithography (STL) formats and sliced in
Modelworks software (Solidscape, Inc.) to fabricate wax
molds using a PatternMaster 3D printer (Solidscape, Inc.).
These wax molds were cast into HAP ceramic negative
molds. Polymer pellets, PLLA (inherent viscosity = 0.65 dL/
g; Birmingham Polymers Inc.) and PCL (molecular weight:
43,000–50,000; Polyscience Inc.), were heated at 205C and
120C, respectively, in a Teflon mold. The HAP molds were
then placed into the Teflon mold containing molten polymer,
in order to force the polymer through the open pore network.
The HAP molds were removed from the porous polymer
scaffolds using RDO Rapid Decalcifier (APEX Engineering
Products Corp.) and washed with 100% ethanol.
Mineral coating incubation in mSBF
Fabricated PLLA and PCL scaffolds were coated in the
same manner (Fig. 1). The scaffolds were hydrolyzed in a
0.1M NaOH for 60min to expose surface carboxylate anions
and alcohol groups that serve as mineral nucleation sites.
Subsequently, samples were rinsed at least three times with
deionized H2O. Scaffolds were incubated at 37C in 15mL of
mSBF for 14 days under continuous rotation. The mSBF so-
lution is similar to human plasma but with double the con-
centration of calcium and phosphate, and was prepared as
previously reported.17 Specifically, the following reagents
were added to ddH2O heated to 37C in the order shown;
141mM NaCl, 4.0mM KCl, 0.5mM MgSO4, 1.0mM MgCl2,
4.2mM NaHCO3, 20.0mM Tris, 5.0mM CaCl2, and 2.0mM
KH2PO4. The solution was then adjusted to a final pH of 6.8.
The mSBF solution was renewed daily to maintain a con-
sistent ionic strength and pH throughout the experiment.
FIG. 1. Poly (L-lactic acid) (PLLA) and poly (e-caprolactone)
(PCL) with designed architectures were fabricated using indi-
rect solid freeform fabrication. Fabricated scaffolds were si-
multaneously coated using modified simulated body fluid.
Color images available online at www.liebertpub.com/tec
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Scaffold surface characterization by SEM
The surfaces of preimplanted scaffolds were examined in
an environmental scanning electron microscope (ESEM),
Philips XL30 ESEM. Imaging was performed in variable
pressure mode at a pressure of 0.7Torr and at an accelerating
voltage of 10 kV. Scaffold surfaces were further investigated
using SEM with X-ray energy disperse spectroscopy (XEDS).
Preimplanted mineral-coated scaffolds were embedded in
epoxy resin (Embed 812, Electron Microscopy Sciences), and
postimplanted mineral coated scaffolds were embedded in
methyl methacrylate (MMA) (Fisher Scientific), N-butyl
methacrylate (Sigma-Aldrich), methyl benzoate (Sigma-
Aldrich), and polyethylene glycol 400 (Fisher Scientific) as
previously described.29–31 The embedded specimens were
sectioned with a microtome using a diamond blade (Isomet;
Buehler) with 200–300 mm thickness. The cross sections were
observed in backscattered electron imaging mode in an FEI
Quanta focused ion beam workstation and environmental
SEM, at a pressure of 0.5 Torr and at an accelerating voltage
of 30 kV.
Mineral coating characterization by XRD
For XRD analysis, the mineral-coated scaffolds were im-
mersed in chloroform (ACROS Organics) and stirred con-
tinuously for 20min or until completely dissolved. The
mixture was then centrifuged at 4000 rpm for 5min to sep-
arate out the mineral component. The mineral was rinsed in
fresh chloroform and centrifuged for a second time. After
collecting the chloroform, the mineral powder was dried
under the hood for 2 days to allow residual chloroform to
evaporate for XRD analysis. XRD patterns were recorded
using a General Area Detector Diffraction System, with a Hi-
star 2-D area detector (20 < 2y < 40) using Cu Ka radiation.
The resulting patterns of the samples were identified by
computer matching with an International Centre for Dif-
fraction Data (ICDD) powder diffraction database (ICDD
card number for HAP: 00-001-1008). XRD patterns of the
coated scaffold surfaces were also measured in a nonde-
structive manner using a Bruker D8 Discover X-ray Dif-
fractometer.
Cell preparation, virus infection and scaffold
implantation in mice subcutaneous sites
Coated scaffolds were loaded with virally transduced
human fibroblasts, as described in previous studies.21,22
Primary human gingival fibroblasts (HGFs) (ScienCell) were
cultured and expanded on passage 6 near confluence in
Dulbecco’s modification of Eagles medium (DMEM) sup-
plemented with 10% fetal bovine serum, and 1% penicillin
and streptomycin (Gibco). The HGFs were infected with
AdCMV-GFP, a recombinant adenovirus construct expres-
sing murine green fluorescent protein gene under a cyto-
megalovirus (CMV) promoter, at a multiplicity of infection of
500 PFU/cell for 20 h. About 0.5 million cells were seeded
into each scaffold by suspending them in 40 mL of 5mg/mL
collagen gel. The gelation procedure was as follows: Rat-tail
collagen high concentration (stock concentration = 9.03mg/
mL; BD Bioscience Discovery Labs) was diluted with cold
sterile 0.02N acetic acid to make 5mg/mL. 0.5N sodium
hydroxide with 220mg/mL sodium bicarbonate was added
to Col I gel mixture to initiate gelation, and gel contents were
mixed with cells and evenly re-suspended. Forty microliters
of cell and gel mixture was placed in each hole of sterilized
custom-made Teflon mold, and the scaffolds were placed on
top of the gel to enforce infiltration. This was followed by
incubation at 37C for 40min to solidify gels further. The
scaffolds seeded with HGFs were transferred in ultra-low
cluster 24-well plate (Corning Incorporated) with DMEM
containing 2% FBS were incubated on an orbital shaker
for 24 h.
The scaffolds were subcutaneously implanted into 6–7-
week-old (46–53-day-old) female immunocompromised mice
(NIHS-bg-nu-xid, Harlan). Animals were anesthetized with
an injection of ketamine/xylazine, 4 subcutaneous pockets
were created, and 4 scaffolds (one scaffold from each group)
were implanted into each mouse. Surgical sites were closed
with wound clips in compliance with the University of Mi-
chigan University Committee on Use and Care of Animal
regulations. The mice were sacrificed at 3 and 10 weeks after
the implantation, and the scaffold and tissue constructs were
harvested, fixed with Z-fix (Anatech), and stored in 70%
ethanol for further assay.
l-CT analysis of fabricated scaffold architectures
and amount of coated mineral
All of the scaffolds were scanned using an MS-130 high-
resolution m-CT Scanner (GE Medical Systems) at a resolu-
tion of 16mm before and after implantation. The resulting
data was analyzed using MicroView software (GE Health-
care). Mineral-coated scaffolds were scanned in Milli-Q wa-
ter to enhance the contrast of the biomineral layer, and
uncoated scaffolds were scanned in air due to polymer radio
transparency when scanned in water. Total immersion time
of the coated scaffolds in Milli-Q was kept to approximately
1.5 h (including scanning time) to minimize the potential
error of mineral dissolution in the water. Each scan was ca-
librated with a calibration phantom containing air, water,
and a material that mimics cortical bone. The calibration
values of air and water were set to - 1000 and 0 Hounsfield
Units (HU), respectively, and the bone HU value was cal-
culated using a standard conversion equation from air and
water values.32 The scanned scaffold images were re-
constructed, stored as .vff files and then processed to deter-
mine the architecture of the uncoated scaffolds and the
amount of mineral on the coated scaffolds.
Pore size, strut size, volume, and surface area were as-
sessed to characterize uncoated scaffold architectures. Pore
size was measured on three orthogonal planes and averaged
to obtain the mean value for each scaffold. Strut sizes were
measured as the material distance between the pores, and
also averaged in the same manner as the pore size. The
volume and surface area of each scaffold were calculated
after applying an isodensity threshold using an Auto-
threshold function in MicroView to render 3D images, which
generated threshold values of - 542.5– 16.5 HU and
- 647.7– 20.3 HU for uncoated PLLA and uncoated PCL
scaffolds, respectively.
To determine the amount of mineral on the scaffold sur-
faces, a cylindrical region of interest (ROI) with 5.6mm di-
ameter and 3.5mm height was chosen to encompass the
whole scaffold, and then the amount of mineral was
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calculated applying various threshold values from 400 to 800
HU by 50 HU increments, similar to techniques for detecting
bone tissue.33,34 The mineral content on the scaffolds after
coating were calculated by subtracting the mineral content
values before implantation from those after implantation
within the ROI.
Calcium content of coated scaffolds
Scaffolds were dissolved in 1mL of 1.0N acetic acid for 3
days (preimplanted scaffolds) or 10 days (postimplanted
scaffolds) to ensure all mineral was dissolved. Calcium de-
posited on scaffolds was quantified using an orthocre-
solphthalein complex-one (OCPC) method in which 10 mL of
the dissolved solution was reacted with 300mL of a working
solution consisting of 0.05mg/mL of OCPC solution and
ethanolamine/boricacid/8-hydroxyquinoline buffer (Sigma)
for 10min at room temperature.35 Samples were read spec-
trophotometrically at 575 nm, and calcium values were
quantified by comparison to a standard curve prepared over
a range of 0–100 mg/mL. Samples were diluted 50-fold as
necessary. In addition, the scaffolds were re-immersed in
acetic acid for three more days, and OCPC method was
performed to confirm there was no remaining calcium on the
scaffolds.
Statistical analysis
Statistical analysis was performed with SPSS (SPSS, Inc.).
Two groups were analyzed with Student’s t-test for inde-
pendent samples. Multiple comparisons were evaluated by
one-way ANOVA followed by Tukey’s Post Hoc multiple
comparisons. Errors are reported in figures as standard de-
viation (SD) and significance was determined using a prob-
ability value of p< 0.05.
Results
Morphology of coated and uncoated scaffolds
PLLA and PCL scaffolds had similar morphology, and
become less transparent after mineral coating (Fig. 2a–d).
Uncoated PLLA and PCL scaffold architectures were ana-
lyzed using m-CT (Fig. 2f, h). Pore size, strut size, volume,
surface area, and surface-to-volume ratio of uncoated PLLA
and PCL scaffolds were measured (N = 6–7) (Table 1). These
values were the same between the PLLA and PCL scaffolds,
which indicates that the scaffolds had identical architectures.
m-CT data also showed the existence of 3D mineral layers
inside of the scaffold architectures (Fig. 2e, g). Since the
polymer has similar density to water, PLLA and PCL scaf-
folds were almost radio transparent and only mineral
FIG. 2. Images, micro-computed
tomography (m-CT) images, and
environmental scanning electron
microscope (ESEM) images of
coated PLLA (a, e, i, m), uncoated
PLLA (b, f, j, n), coated PCL (c, g, k,
o) and uncoated PCL (d, h, l, p). m-
CT images confirm that mineral
layer covered the surface of both
PLLA and PCL scaffolds (e, g).
ESEM images show that rough
surface of the coated PLLA and
PCL scaffolds (m, o), while
relatively smooth surface of the
uncoated PLLA and PCL scaffolds
(n, p). Color images available
online at www.liebertpub.com/tec
Table 1. Micro-Computed Tomography Measurements of Fabricated Uncoated Poly (L-Lactic Acid)
and Poly (e-Caprolactone) Scaffolds
Pore size (mm) Strut size (mm) Volume (mm3) Surface (mm2) Surface/volume
PLLA Scaffold 0.60 – 0.03 0.67 – 0.03 33.26– 2.19 187.13– 13.75 5.63 – 0.20
PCL Scaffold 0.61 – 0.04 0.67 – 0.03 30.97– 1.29 182.22– 10.82 5.88 – 0.13
PLLA, poly (L-lactic acid); PCL, poly (e-caprolactone).
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coatings were visible in the CT images. Scaffold surfaces
were further characterized using ESEM (Fig. 2i–p). Uncoated
PLLA and PCL scaffolds had smooth surfaces (Fig. 2j, l, n, p),
while mineral coated PLLA and PCL scaffolds had rough
surfaces (Fig. 2i, k, m, o).
Nanoscale plate-like crystalline structures were observed
on both coated PLLA and PCL scaffolds (Fig. 3a, b) as
observed in previous studies of mineral coatings on bio-
resorbable polymers. Analysis of biomineral composition by
XEDS showed that the mineral was composed primarily of
calcium and phosphorous with a Ca/P ratio of 1.58 for
coated PLLA scaffold (Fig. 3c) and 1.56 for coated PCL
scaffold (Fig. 3d), which are in the range of biological apatite.
These data support growth of bone-like HAP minerals on the
surface of the scaffolds.
Crystallinity
Both biomineral-coated PLLA and PCL scaffolds were
dissolved in chloroform to obtain biomineral crystallinity
(Fig. 4a,b). The data shows that coated PLLA and PCL scaf-
folds crystal peaks were similar to those of HAP. Crystallinity
of the mineral-coated scaffolds was also detected without
dissolving the polymer component in chloroform. The coated
PLLA showed major peaks at 2y= 25.9 and 31.95 (Fig. 4c),
consistent with the major crystalline peaks of HAP, while the
uncoated PLLA scaffold showed many peaks due to its semi-
crystalline structures (Fig. 4d). In contrast, the coated PCL also
clearly showed crystal peaks at 2y = 25.9 and 31.95 (Fig. 4e),
while the uncoated PCL scaffolds had amorphous structures
and did not show crystal peaks of polymer (Fig. 4f ).
FIG. 3. Scanning electron microscopy (SEM) images and X-
ray energy disperse spectroscopy (XEDS) data of coated
minerals of PLLA (a, c) and PCL (b, d) scaffolds. SEM images
show that nucleated bone like mineral structures on the
coated PLLA and PCL scaffolds (a, b). XEDS data confirmed
that existence of calcium and phosphorous peaks (c, d).
FIG. 4. X-ray diffraction (XRD) data was obtained mineral-coated scaffolds after dissolving them in chloroform, coated PLLA
(a) and coated PCL (b). Mineral peaks reflecting HAP pattern were shown. XRD data of surface of the scaffolds is also shown,
coated PLLA (c), uncoated PLLA (d), coated PCL (e), and uncoated PCL (f ), and the coated PLLA scaffold shows their peak at
2y= 25.9 and 31.95 (c), and the uncoated PLLA scaffold shows many peaks due to its semi-crystalline structures (d). The coated
PCL also show their crystal peaks at 2y= 25.9 and 31.95 (e). Color images available online at www.liebertpub.com/tec
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Cross section of mineral-coated scaffolds
Figure 5 shows the SEM images of mineral-coated scaf-
folds, coated PLLA (a), and coated PCL (b). Images show
mineral layers as white color and polymers, scaffold and
MMA, as dark gray. The magnified areas of yellow boxes
show the coating thickness ranging from 20 to 30 mm on the
coated PLLA (Fig. 5c) and PCL scaffolds (Fig. 5d) with some
discontinuous parts of mineral layers.
Determining the relation between l-CT
and calcium assay of preimplanted scaffolds
Various threshold values in CT images were applied to
visualize the biomineral coating on PLLA and PCL scaffolds
(Fig. 6a). Yellow indicates biomineral that has higher density
than the applied threshold values, while white indicates
biomineral with lower density than the threshold values.
Changing the value, the images shows more background at
lower threshold, and less biomineral coating was detected at
higher threshold. To find the optimal relationship between
tissue mineral content (TMC) from m-CT and the amount of
calcium, a range of threshold values were examined. For
threshold values ranging from 400 to 800 HU by 50 HU, a
value of 600 HU showed the highest R-squared value (0.96)
(Fig. 6a, b). The relation between volume of mineral layers
from m-CT and amount of calcium also showed a strong
correlation (R2 = 0.96) (Fig. 6c). The results indicated that
mineral density calculated by m-CT is significantly correlated
with the amount of calcium measured by OCPC method.
FIG. 5. SEM images of mineral-coated scaffolds embedded
and sectioned in methyl methacrylate (MMA), coated PLLA
(a) and coated PCL (b). The magnified areas of yellow boxes
are also shown, coated PLLA (c) and coated PCL (d). Images
show that mineral layers as white color and polymers,
scaffold and MMA, as dark gray. The mineral layers existed
on the surface of porous scaffolds within coated PLLA and
PCL scaffolds.
FIG. 6. Yellow color indicates biomineral coatings on the scaffold surface by varying the threshold values of m-CT from 200
to 1000 (a). R-squared values of correlation between amount of calcium (mg) from orthocresolphthalein complex-one (OCPC)
method and tissue mineral content (mg) from m-CT data (b). Threshold values were varied from 400 to 800 HU by 50 HU, and
the highest R-squared value (0.96) at threshold value with 600 HU. The relation between calcium amount and Tissue mineral
content (TMC) (c) and volume from m-CT data (d) are also shown. The R-squared values between calcium amount and
volume from m-CT data (d) is 0.96. Color images available online at www.liebertpub.com/tec
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Uncoated PLLA and PCL scaffolds showed calcium values
similar to background.
Mineral coatings on implanted scaffolds
Mineral coatings on the scaffolds after implantation were
examined using backscattered SEM (Fig. 7). The images
show that the mineral layers covered the scaffolds, following
the scaffold architectures and pore outlines at 3 (Fig. 7a,c)
and 10 (Fig. 7e, g) weeks implantation. From the magnified
images, the thickness of the mineral layers observed at 3
weeks (Fig. 7b, d) at 10 weeks (Fig. 7f, h) indicates that the
thickness does not decrease.
Quantifying biomineral coating on the scaffold
after implantation
The implanted scaffolds were covered with soft tissue and
the surface mineral was not visualized. The scaffolds with
tissue were scanned in Milli-Q water using m-CT. The data
show that the mineral coating layers were observed through-
out the study period on the coated scaffolds (Fig. 8a–d), and
there is an apparent increase in the intensity of mineral coating
at 10 weeks compared to 3 weeks. Although the scaffolds were
covered with soft tissues, the tissues were close to radio
transparent under m-CT.
The amount of calcium on the implanted scaffolds surfaces
was also measured using the OCPC method. The coated
scaffolds showed the existence of calcium, while the un-
coated scaffolds had calcium values similar to background.
The relationship between TMC and the amount of calcium
from OCPC were examined varying the threshold values
from 400 to 800 HU. The highest R-squared value (0.90) was
again obtained at a threshold value of 600 HU (Fig. 8e, f ).
The amount of calcium by OCPC again showed a strong
correlation to mineral volume from m-CT data with an
R-squared value of 0.89 (Fig. 8g). Since mineral volume from
m-CT data are correlated with amount of calcium the OCPC
assay, the amount of mineral before and after implantation
were calculated from m-CT data. The data shows that mineral
volume increased after implantation (Fig. 9). The amount of
deposited mineral layers calculated from m-CT indicated
significantly more mineral deposition at 10 weeks than
3 weeks for both the coated PLLA ( p= 0.001) and PCL
( p = 0.029) scaffolds (N = 6). Furthermore, the 10-week im-
planted coated PLLA scaffolds had significantly more min-
eral deposition than the 3-week ( p= 0.000) and 10-week
( p = 0.002) implanted coated PCL scaffolds (N = 6).
Discussion
Biomineral coatings have been applied to porous polymer
scaffolds to improve bone regeneration. We demonstrated
that a m-CT technique can be used to quantify the amount of
biomineral coatings on porous scaffolds before and after
implantation. First, we demonstrated that our mSBF tech-
nique was applicable to two different biodegradable scaf-
folds made of PLLA and PCL using indirect SFF. The mineral
morphology and composition on the scaffold surfaces were
confirmed using conventional techniques, SEM and XRD.
Mineral coatings within the porous scaffolds were shown
using plastic embedding and m-CT techniques. Finally, the
amount of minerals in each scaffold was quantified using m-
CT and compared with OCPC techniques, which provided a
standard for the m-CT based quantification.
By fabricating scaffolds using indirect SFF, it was possible
to achieve two important objectives. First, the same archi-
tecture could be built from two different biomaterials, al-
lowing us to test coating effects on two different material
substrates without the confounding effects of different ar-
chitectures. Second, fully connected pore structures could be
created by indirect SFF.21,22 The fabricated PLLA and PCL
scaffolds were characterized using m-CT to confirm that both
FIG. 7. Cross section of the implanted coated PLLA and PCL scaffolds at 3 (a, c) and 10 (e, g) weeks postimplantation,
respectively. The mineral layers existed on the scaffold surfaces, following the scaffold architectures and pore outlines.
The magnified areas of the yellow boxes are also shown, coated PLLA and coated PCL, at 3 (b, d) and 10 (f, h) weeks,
respectively. The thickness of the mineral layers observed indicates that the thickness does not decrease.
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scaffolds had identical fully interconnected pore architec-
tures that would allow efficient penetration of SBF to the
scaffold interior.
The fabricated PLLA and PCL scaffolds were treated with
mSBF, and the successful growth of biomineral surface
coatings was confirmed. SEM images of mineral morpholo-
gies show plate-like structures, calcium to phosphorous ratio
and crystal peaks similar to our previous studies of mineral-
coated hydrogels, bioceramics, and biodegradable poly-
mers.17,36–39 XRD results showed both coated scaffolds
showed crystal peaks of mineral at 26 and 32, which cor-
respond to the (002) plane and (211) (112) planes of apatite.40
Coated PLLA showed a peak at 32, and other peaks due to
the crystal structure of PLLA polymer, which were con-
firmed from the XRD data of uncoated PLLA scaffolds.41 In
contrast, coated PCL showed two peaks from the PCL
polymer around 21 and 24, similar to previous studies.36,42
All of these data confirm that the PLLA and PCL scaffolds
were successfully coated with biomineral layers similar to
those of previous studies using destructive (OCPC, XRD,
and SEM) and nondestructive (m-CT) methods.
It is very important to assess mineral coatings within po-
rous architectures, such as thickness of mineral layer, which
has been done via cutting or breaking without embedding.18
However, these techniques were not applicable to SFF scaf-
folds, especially PLLA and PLGA scaffolds, since they are
much stiffer than scaffolds fabricated using porogen leaching
methods.16,21 Therefore, to access the cross section of the
mineral layers, plastic embedding techniques were utilized
and showed the mineral layers covered the inside of the
porous scaffolds and also followed the SFF scaffolds archi-
tectures. This section technique allowed demonstration of
coating on both pre- and postimplanted scaffolds by SEM
without losing the scaffold structures.
m-CT has been utilized to achieve nondestructive quanti-
fication of 3D mineral coatings on porous scaffolds. Since
the density of the polymer is lower than that of mineral and
close to water, the scaffolds scanned in water helped make
the polymer invisible and increase intensity of mineral
coating.14 Although previous studies showed that m-CT may
be applicable to monitor in vitro mineralization of porous
scaffolds,19,43,44 the accuracy of measured mineral coatings
FIG. 8. m-CT images of implanted coated PLLA at 3 (a) and 10 (c) weeks, and implanted coated PCL at 3 (b) and 10 (d)
weeks. R-squared values of correlation between amount of calcium (mg) from OCPC method and tissue mineral content (mg)
from m-CT data (e). Threshold values were varied from 400 to 800 HU by 50 HU, and the highest R-squared value (0.90) were
achieved at threshold with 600 HU, as the relation shown (f ). The calcium amount and volume from m-CT data were
correlated strongly with R-squared value of 0.89 (g). Color images available online at www.liebertpub.com/tec
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by m-CT has not been examined. Therefore, to evaluate the
accuracy of m-CT data and qualify the amount of mineral,
TMC and mineral volume from m-CT data were compared
with the amount of calcium in the mineral layers using
OCPC method which has been used to characterize bio-
mineral coatings.35,45
TMC from m-CT and OCPC data showed a strong corre-
lation when the threshold values ranged from 400 to 800 HU.
However, R-squared values and image contrasts of mineral
parts were varied by changing the threshold values of the m-
CT data, indicating the importance of choosing proper
threshold values. The optimized threshold value, 600 HU, was
found to produce a strong correlation between m-CT and
OCPC data of the preimplanted scaffolds. Then, comparison
between m-CT and OCPC data was further performed on the
postimplanted scaffolds. The soft tissue covering the scaffolds
was less visible due to the low x-ray contrast of non-
mineralized tissues,46 which allowed examination of the
mineral layers of the scaffolds. The m-CT data showed strong
correlation with OCPC data at the same optimal threshold
value of 600 HU with the preimplanted scaffolds although the
R-squared value was not as strong that of the preimplanted
scaffolds. This may be because soft tissue covering the scaf-
folds interrupts dissolution of calcium or intensity of minerals
in m-CT data. Our study further proves that m-CT can be used
to quantify relative changes to biomineral coatings on both
pre- and post-implanted scaffolds and suggest proper neces-
sity of threshold values for mineral quantification.
Based on a strong correlation between the m-CT data and
calcium assay, we further applied m-CT analysis to calculate
mineral the difference in the amount of before and after
implantation. The data showed a slight but significant in-
crease of mineral on the scaffolds with longer implantation,
while the SEM images only showed the 2D existence of
mineral on the scaffold surface. These results support the use
of m-CT as a nondestructive method to assess the change in
mineralization on the same scaffold before and after im-
plantation. In future work, an in vivo m-CT system may be
used to track the change of minerals on scaffold surfaces
without harvesting scaffolds.
The m-CT data of the scaffolds with GFP-transduced HGFs
demonstrated an increasing mineral layer accumulation on
the scaffold, similar to that previously seen with carbonate
apatite absorption in rat ectopic sites.47 Although we have
not investigated the mechanism of biomineral deposition
in vivo, the observed slight increase in mineral content be-
tween week 3 and week 10 of implantation could potentially
be due to a heterogeneous precipitation of new mineral on
the initial mineral coatings, as the in vivo environment is
often supersaturated with respect to HAP mineral. It is less
likely that mineralized tissue is being formed within the
scaffolds as ectopic mineralized tissue formation has not
been commonly observed in rodent subcutaneous sites.
Further study is needed into the mechanism for the observed
increase in mineral content over time in vivo.
A limitation of this study is that the method used to
quantify minerals using m-CT may not be applicable in its
current form when mineral-coated scaffolds are implanted
long term into bony sites due to the difficulty of separating
initial biomineral coating and newly growing bone tissue. It
also needs to be noted that the optimal thresholds may vary
depending on biomineral coating techniques with different
mineral morphologies, necessitation further study of the re-
lation between optimal threshold values and various bio-
mineral techniques.
Conclusions
Biomineral coating has been applied to porous scaffolds to
improve bone regeneration. We have applied biomineral
coating on SFF PLLA and PCL scaffolds to ensure that
mineral coatings were achieved within the same porous ar-
chitecture. Biomineral layers were confirmed to have similar
quantity to previously reported mineral coatings on 3D po-
rous architectures. Furthermore, m-CT was utilized to qualify
and quantify the amount biomineral coating within the
scaffolds in a nondestructive manner. The nondestructive m-
CT results showed a strong correlation with destructive
OCPC calcium characterization, validating the use of m-CT to
verify the effect of ectopic implantation on coating evolution.
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FIG. 9. The amount of deposited mineral layers calculated
from m-CT where the differences of mineral volume were
calculated by subtracting postimplant scaffolds from pre-
implant scaffolds. There were significantly more mineral
deposition at 10 weeks than 3 weeks for both the coated
PLLA ( p= 0.001) and PCL ( p= 0.029) scaffolds *(N = 6). Fur-
thermore, the 10-week implanted coated PLLA scaffolds had
significantly more mineral deposition than the 3-week
( p= 0.000) and 10-week ( p= 0.007) implanted PCL scaffolds
**(N = 6).
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